Injecto Polymers Share Price & Earnings Call Analysis
₹93.49+2.23% today
- Market cap
- ₹194 Cr
- P/E
- 12.15
- ROE
- 28.93%
- PEG
- 0.12
- Price to sales
- 0.52
- Debt to equity
- 2.61
- Sales growth (5Y)
- 50.24%
- EBITDA margin
- 10.06%
- Net profit margin
- 4.26%
- Promoter holding
- 64.34%
- Sales (last year)
- ₹376 Cr
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Injecto Polymers
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Injecto Polymers
Shareholding breakup across reporting periods.
| Sep 2026 | |
|---|---|
| Promoters + | 64.34% |
| FIIs + | 7.68% |
| Public + | 27.98% |
| No. of Shareholders | 952 |
Financials of Injecto Polymers
Quarterly Results
Quarter-by-quarter operating performance
| Sales + |
| Expenses + |
| Operating Profit |
| OPM % |
| Other Income + |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit + |
| EPS in Rs |
Financials of Injecto Polymers
Profit & Loss
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 49 | 88 | 96 | 109 | 261 | 376 |
| Expenses + | 44 | 81 | 88 | 97 | 239 | 338 |
| Operating Profit | 5 | 6 | 8 | 12 | 23 | 38 |
| OPM % | 9% | 7% | 8% | 11% | 9% | 10% |
| Other Income + | 0 | 2 | 0 | 1 | 0 | 1 |
| Interest | 3 | 5 | 5 | 6 | 9 | 12 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 3 |
| Profit before tax | 1 | 1 | 1 | 5 | 11 | 23 |
| Tax % | -75% | 15% | -56% | 10% | 28% | 32% |
| Net Profit + | 1 | 1 | 2 | 4 | 8 | 16 |
| EPS in Rs | 15.76 | 12.55 | 17.65 | 3.32 | 5.34 | 10.55 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% |
Financials of Injecto Polymers
Balance Sheet
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 12 | 13 | 15 | 15 |
| Reserves | 2 | 3 | 6 | 8 | 32 | 48 |
| Borrowings + | 29 | 57 | 64 | 83 | 101 | 165 |
| Other Liabilities + | 15 | 20 | 27 | 17 | 22 | 42 |
| Total Liabilities | 55 | 89 | 108 | 121 | 171 | 271 |
| Fixed Assets + | 15 | 33 | 32 | 33 | 41 | 42 |
| CWIP | 13 | -0 | 2 | 2 | 2 | 1 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Assets + | 27 | 56 | 74 | 86 | 128 | 228 |
| Total Assets | 55 | 89 | 108 | 121 | 171 | 271 |
Financials of Injecto Polymers
Cash Flows
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 10 | -16 | -2 | -13 | -17 | -49 |
| Cash from Investing Activity + | -11 | -6 | -3 | -3 | -9 | -3 |
| Cash from Financing Activity + | 1 | 22 | 5 | 16 | 26 | 52 |
| Net Cash Flow | 0 | 0 | -0 | -0 | -0 | -0 |
| Free Cash Flow | -1 | -22 | -5 | -16 | -26 | -52 |
| CFO/OP | 228% | -258% | -29% | -103% | -71% | -124% |
Financials of Injecto Polymers
Ratios
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 122 | 117 | 115 | 105 | 50 | 62 |
| Inventory Days | 54 | 105 | 167 | 175 | 126 | 165 |
| Days Payable | 104 | 92 | 125 | 56 | 26 | 34 |
| Cash Conversion Cycle | 72 | 130 | 157 | 224 | 149 | 194 |
| Working Capital Days | 20 | 109 | 42 | 53 | 21 | 24 |
| ROCE % | 12% | 9% | 12% | 16% | 19% |